This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Genmab Holding B.v.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Martine Ed Chamuleau: Innovator in Antibody Research
Introduction
Martine Ed Chamuleau is a prominent inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of antibody research, particularly in the development of therapeutic antibodies. Her work has the potential to impact the treatment of various diseases.
Latest Patents
Martine holds a patent for "Methods of Use of Anti-CD37 Antibodies, Monoclonal Anti-CD37 Antibodies." This patent highlights her innovative approach to utilizing antibodies in medical applications, showcasing her expertise in the field.
Career Highlights
Martine is currently associated with Genmab Holding B.V., a leading biotechnology company focused on the development of differentiated antibody therapeutics for the treatment of cancer. Her role at Genmab has allowed her to collaborate with other experts in the field, further enhancing her contributions to medical science.
Collaborations
Some of her notable coworkers include Frank Beurskens and Paul Parren. Their collaborative efforts have been instrumental in advancing research and development in antibody therapies.
Conclusion
Martine Ed Chamuleau is a trailblazer in the field of antibody research, with a patent that underscores her innovative contributions. Her work at Genmab and collaborations with esteemed colleagues continue to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile